PFO
MRTX

Pathstone Family Office’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Pathstone Family Office’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7
Closed -$2K – 1388
2020
Q4 		$2K Buy
+7
New +$2K ﹤0.01% 1036
2020
Q3 		– Sell
-100
Closed -$11K – 1046
2020
Q2 		$11K Buy
+100
New +$11K ﹤0.01% 508